Article Details

Arcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 ...

Retrieved on: 2021-01-16 15:19:53

Tags for this article:

Click the tags to see associated articles and topics

Arcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 .... View article details on hiswai:

Excerpt

To date, addition of anti-PD-1 antibodies to gemcitabine/nab-paclitaxel in ... Zimberelimab (AB122), Arcus's anti-PD-1 monoclonal antibody, was ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up